DIN 02281066 — ABRAXANE FOR INJECTABLE SUSPENSION 100 MG
ABRAXANE FOR INJECTABLE SUSPENSION is a powder for suspension of Paclitaxel marketed by BRISTOL-MYERS SQUIBB CANADA. The full Paclitaxel monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02281066
- Brand name
- ABRAXANE FOR INJECTABLE SUSPENSION
- Active ingredient
- Paclitaxel
- Strength
- 100 MG
- Dosage form
- POWDER FOR SUSPENSION
- Route
- INTRAVENOUS
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent (taxane, antimicrotubule agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Paclitaxel products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02248844 | APO-PACLITAXEL INJECTABLE | 6 MG | SOLUTION | APOTEX INC | DORMANT |
| 02244372 | PACLITAXEL FOR INJECTION | 6 MG | SOLUTION | BIOLYSE PHARMA CORPORATION | MARKETED |
| 02320010 | PACLITAXEL FOR INJECTION USP | 6 MG | SOLUTION | STERIMAX INC | DORMANT |
| 02320150 | PACLITAXEL INJECTION USP | 6 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02391465 | PACLITAXEL INJECTION USP | 6 MG | SOLUTION | ACCORD HEALTHCARE INC | MARKETED |
| 02496097 | PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL | 100 MG | POWDER FOR SUSPENSION | PANACEA BIOTEC PHARMA LIMITED | MARKETED |